You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MOSAIC

Showing 1 - 25 of 235
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intimate Partner Violence, Depression, Posttraumatic Stress Symptom Trial (MOSAIC Plus)

Not yet recruiting
  • Intimate Partner Violence
  • +2 more
  • MOSAIC Plus
  • (no location specified)
Jul 31, 2023

Skin Texture Disorder, Photoaging, Wrinkle Trial in Lincolnshire, Billerica, Peabody (Mosaic)

Recruiting
  • Skin Texture Disorder
  • +6 more
  • Mosaic
  • Lincolnshire, Illinois
  • +2 more
Nov 1, 2023

Intimate Partner Violence, Depression, Post Traumatic Stress Disorder Trial (MOSAIC Plus, MOSAIC)

Not yet recruiting
  • Intimate Partner Violence
  • +2 more
  • MOSAIC Plus
  • MOSAIC
  • (no location specified)
Apr 6, 2022

Influenza Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (VRC-FLUMOS0116-00-VP( FLUMos-v2))

Recruiting
  • Influenza
  • VRC-FLUMOS0116-00-VP( FLUMos-v2)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 4, 2023

Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)

Completed
  • Human Immunodeficiency Virus
  • Ad26.Mos4.HIV
  • +3 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Feb 7, 2022

Heart Transplant, Immunosuppression, Allograft Trial (HeartCare)

Not yet recruiting
  • Heart Transplant
  • +2 more
  • HeartCare
  • (no location specified)
Jul 12, 2022

HIV Trial in Oxford (ChAdOx1.tHIVconsv1 (C1), MVA.tHIVconsv3 (M3), MVA.tHIVconsv4 (M4))

Completed
  • HIV
  • ChAdOx1.tHIVconsv1 (C1)
  • +2 more
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 10, 2022

Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

Completed
Has Results
  • Human Immunodeficiency Virus
  • Ad26.Mos.HIV
  • +2 more
  • Bangkok, Thailand
    (unnamed)
Dec 29, 2021

Influenza, Seasonal Influenza Trial run by the NIAID (VRC-FLUMOS0111-00-VP (FluMos-v1), Flucelvax)

Active, not recruiting
  • Influenza
  • Seasonal Influenza
  • VRC-FLUMOS0111-00-VP (FluMos-v1)
  • Flucelvax
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Aneuploidy, Mosaicism Trial in Sunnyvale (Non-euploid embryo transfer, Euploid Transfer)

Recruiting
  • Aneuploidy
  • Mosaicism
  • Non-euploid embryo transfer
  • Euploid Transfer
  • Sunnyvale, California
    Stanford Fertility and Reproductive Medicine Center
Jan 27, 2022

iMmune SignAtures and Clinical outComes in AP

Recruiting
  • Acute Pancreatitis
  • CyTOF Analysis
  • Los Angeles, California
  • +4 more
May 17, 2023

HIV-1-infection Trial in London (ConM SOSIP, EDC ConM SOSIP, ConS UFO)

Active, not recruiting
  • HIV-1-infection
  • ConM SOSIP
  • +4 more
  • London, United Kingdom
    NIHR Imperial Clinical Resarch Facility
Jul 25, 2022

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome Trial in Worldwide (Miransertib)

Terminated
  • PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome
  • Atlanta, Georgia
  • +10 more
May 10, 2022

HIV Trial (DNA Nat-B env vaccine, NYVAC Nat-B env vaccine, DNA CON-S env vaccine)

Withdrawn
  • HIV Infections
  • DNA Nat-B env vaccine
  • +7 more
  • (no location specified)
Oct 13, 2021

Healthy Trial in Worldwide (Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo)

Active, not recruiting
  • Healthy
  • Ad26.Mos4.HIV
  • +2 more
  • Birmingham, Alabama
  • +52 more
Jan 17, 2023

Management of Robertsonian Translocation PGT-SR Attempts

Completed
  • Robertsonian Translocation
    • Montpellier, France
      Uhmontpellier
    Nov 8, 2021

    HIV Trial in Switzerland, United States (DNA Nat-B env, DNA CON-S env, DNA Mosaic env)

    Completed
    • HIV Infections
    • DNA Nat-B env
    • +7 more
    • Birmingham, Alabama
    • +6 more
    Oct 13, 2021

    HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

    Not yet recruiting
    • HIV-1-infection
    • ChAdOx1.tHIVconsv1
    • +7 more
    • San Diego, California
    • +11 more
    Oct 4, 2023

    HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)

    Active, not recruiting
    • HIV-1-infection
    • Vaccine
    • Placebo
    • Kilifi, Kenya
    • +3 more
    Jun 21, 2022

    COVID-19 Trial in Canada (mRNA-1273 SARS-CoV-2 vaccine, BNT162b2, ChAdOx1-S [recombinant])

    Recruiting
    • COVID-19
    • mRNA-1273 SARS-CoV-2 vaccine
    • +4 more
    • Edmonton, Alberta, Canada
    • +7 more
    Mar 7, 2022

    Acute Myeloid Leukemia Trial in Germany (MODULE: conventional chemo (Cytarabine+Daunorubicin) in combination with

    Active, not recruiting
    • Acute Myeloid Leukemia
    • MODULE: conventional chemotherapy (Cytarabine+Daunorubicin) in combination with midostaurin+GO
    • +4 more
    • München, Bayern, Germany
    • +10 more
    Aug 31, 2021

    Coronary Microcirculatory Disease and Inflammation in Chronic

    Recruiting
    • Coronary Artery Disease
    • +4 more
    • Comprehensive functional diagnostics of coronary circulation
    • Krakow, Lesser Poland, Poland
      Department of Interventional Cardiology, John Paul II Hospital,
    Mar 29, 2022

    Schizophrenia, Mood Disorders, Substance Dependence Trial in Baltimore, Catonsville (Behavioral Treatment for Substance Abuse in

    Completed
    • Schizophrenia
    • +2 more
    • Behavioral Treatment for Substance Abuse in SPMI (BTSAS)
    • +2 more
    • Baltimore, Maryland
    • +3 more
    Feb 2, 2022

    Schizophrenia Trial in Baltimore, Catonsville (Computer Assisted Cognitive Remediation (CACR))

    Completed
    • Schizophrenia
    • Computer Assisted Cognitive Remediation (CACR)
    • Baltimore, Maryland
    • +2 more
    Jul 14, 2021

    HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

    Completed
    • HER2-positive Breast Cancer
    • +5 more
    • Tucson, Arizona
    • +15 more
    Dec 22, 2022